TY - JOUR
T1 - Oxidized-LDL Induces Metabolic Dysfunction in Retinal Pigment Epithelial Cells
AU - Tomomatsu, Manami
AU - Imamura, Naoto
AU - Izumi, Hoshimi
AU - Watanabe, Masatsugu
AU - Ikeda, Masataka
AU - Ide, Tomomi
AU - Uchinomiya, Shohei
AU - Ojida, Akio
AU - Jutanom, Mirinthorn
AU - Morimoto, Kazushi
AU - Yamada, Ken Ichi
N1 - Publisher Copyright:
© 2024 Pharmaceutical Society of Japan. All rights reserved.
PY - 2024/3
Y1 - 2024/3
N2 - Recently, mitochondrial dysfunction has gained attention as a causative factor in the pathogenesis and progression of age-related macular degeneration (AMD). Mitochondrial damage plays a key role in metabolism and disrupts the balance of intracellular metabolic pathways, such as oxidative phosphorylation (OXPHOS) and glycolysis. In this study, we focused on oxidized low-density lipoprotein (ox-LDL), a major constituent of drusen that accumulates in the retina of patients with AMD, and investigated whether it could be a causative factor for metabolic alterations in retinal pigment epithelial (RPE) cells. We found that prolonged exposure to ox-LDL induced changes in fatty acid β-oxidation (FAO), OXPHOS, and glycolytic activity and increased the mitochondrial reactive oxygen species production in RPE cells. Notably, the effects on metabolic alterations varied with the concentration and duration of ox-LDL treatment. In addition, we addressed the limitations of using ARPE-19 cells for retinal disease research by highlighting their lower barrier function and FAO activity compared to those of induced pluripotent stem cell-derived RPE cells. Our findings can aid in the elucidation of mechanisms underlying the metabolic alterations in AMD.
AB - Recently, mitochondrial dysfunction has gained attention as a causative factor in the pathogenesis and progression of age-related macular degeneration (AMD). Mitochondrial damage plays a key role in metabolism and disrupts the balance of intracellular metabolic pathways, such as oxidative phosphorylation (OXPHOS) and glycolysis. In this study, we focused on oxidized low-density lipoprotein (ox-LDL), a major constituent of drusen that accumulates in the retina of patients with AMD, and investigated whether it could be a causative factor for metabolic alterations in retinal pigment epithelial (RPE) cells. We found that prolonged exposure to ox-LDL induced changes in fatty acid β-oxidation (FAO), OXPHOS, and glycolytic activity and increased the mitochondrial reactive oxygen species production in RPE cells. Notably, the effects on metabolic alterations varied with the concentration and duration of ox-LDL treatment. In addition, we addressed the limitations of using ARPE-19 cells for retinal disease research by highlighting their lower barrier function and FAO activity compared to those of induced pluripotent stem cell-derived RPE cells. Our findings can aid in the elucidation of mechanisms underlying the metabolic alterations in AMD.
UR - http://www.scopus.com/inward/record.url?scp=85188501316&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85188501316&partnerID=8YFLogxK
U2 - 10.1248/bpb.b23-00849
DO - 10.1248/bpb.b23-00849
M3 - Article
C2 - 38508744
AN - SCOPUS:85188501316
SN - 0918-6158
VL - 47
SP - 641
EP - 651
JO - Biological and Pharmaceutical Bulletin
JF - Biological and Pharmaceutical Bulletin
IS - 3
ER -